DFU wound closure at 12 weeksRCT compared PuraPly®AM plus standard of care to standard of care aloneResults strengthen existing clinical evidence supporting future coverage CANTON, Mass., April 06, ...

术后疼痛管理是临床未被充分满足的重大需求，FDA及医疗界对此高度关注。美国Pacira公司开发的布比卡因脂质体（Exparel），采用DepoFoam多囊泡脂质体技术，以实现布比卡因缓释，是改良型长效镇痛代表药物。原研公司向FDA提交的申报资料表明，镇痛时间长达24小时以上，并可减少阿片类药物使用。Pacira公布的2025年报数据披露 ...

Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...

Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial Patients with advanced lung cancer reporting at least moderate ...

A new working paper finds that preschool classrooms where teachers received an intervention designed to strengthen curriculum implementation, effective teaching practices, and teachers' engagement ...

Malaria control and elimination is threatened by the spread of insecticide resistance and behavioral adaptation of vectors. Whether mass administration of ivermectin, a broad-spectrum antiparasitic ...

Targeted indoor residual spraying focuses insecticide applications on common resting surfaces of Aedes aegypti mosquitoes (an arboviral disease vector) in houses, such as exposed lower sections of ...

Organogenesis Holdings Inc. ORGO shares are up during Tuesday’s premarket session following the company’s announcement of achieving the primary endpoint in a randomized controlled trial evaluating ...

作者：刘辉&罗素素“医生，我的肝癌不能切，还能治吗？”“能，我们的目标不只是延命，而是让它像慢病一样可控。”在过去，肝癌意味着发现即晚期；而今天，得益于靶向治疗与免疫治疗的联合突破，肝癌正在从绝症走向可控慢病。一、从无药可治到多线可选：肝癌治疗的巨变 ...